Abstract
The clinical presentation and radiographic appearance of PCNSL differ in immunocompetent and immunocompromised patients and are non-specific for both. A cranial MRI revealing a homogenously enhancing, single lesion in a periventricular location is suggestive of PCNSL in the immunocompetent patient. After neuroimaging suggestive of PCNSL, definitive diagnosis should be established by analysis of CSF, vitreous fluid, or biopsy specimen. Brain biopsy remains the gold standard for PCNSL diagnosis in all patients. At the time of diagnosis, the patient should undergo an extent of disease evaluation as recommended by the International PCNSL Collaborative Group (IPCG). This evaluation includes a physical examination; ophthalmological evaluation with a slit-lamp examination; body CT scans; contrast-enhanced brain MRI; lumbar puncture, if safe; bone marrow biopsy; serum LDH; and HIV serology. Testicular ultrasound, for men, and body FDG-PET should also be considered. Baseline and serial evaluation of cognitive function is critical in this patient population, as both the tumor and anti-tumor therapy are capable of negatively impacting neuropsychological function. Prognostic scoring systems are emerging for the PCNSL patient population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199–201
Kadan-Lattick NS, Skluzacek MC, Gurney JG (2002) Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95:193–202
Batchelor T, Loeffler J (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288
Josephson SA, Papanastassiou AM, Berger MS et al (2007) The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg 106:72–75
Weller M (1999) Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 43:237–239
Mathew BS, Carson K, Grossman SA (2006) Initial response to glucocorticoids. Cancer 106:383–387
Bataille B, Delwail V, Menet E et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261–266
Kiewe P, Fischer L, Martus P et al (2010) Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort. Neurooncology 12:409–417
Balmaceda C, Gaynor JJ, Sun M et al (1995) Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 38(2):202–209
Grimm SA, Pulido JS, Jahnke K et al (2007) Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol 18:1851–1855
DeAngelis LM (1990) Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol 9:177–181
Buhring U, Herrlinger U, Krings T et al (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393–396
DeAngelis LM (1993) Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol 33:308–311
Holtas S, Nyman U, Cronqvist S (1984) Computed tomography of malignant lymphoma of the brain. Neuroradiology 26:33–38
Jack CR Jr., O’Neill BP, Banks PM, Reese DF (1988) Central nervous system lymphoma: histologic types and CT appearance. Radiology 167:211–215
Johnson BA, Fram EK, Johnson PC, Jacobowitz R (1997) The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. Am J Neuroradiol 18:563–572
Lee YY, Bruner JM, Van Tassel P, Libshitz HI (1986) Primary central nervous system lymphoma: CT and pathologic correlation. Am J Roentgenol 147:747–752
Roman-Goldstein SM, Goldman DL, Howieson J et al (1992) MR of primary CNS lymphoma in immunologically normal patients. Am J Neuroradiol 13:1207–1213
Watanabe M, Tanaka R, Takeda N et al (1992) Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain. Neuroradiology 34:36–42
Kuker W, Nagele T, Korfel A et al (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72:169–177
Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853
Barajas RF, Rubenstein JL, Chang JS et al (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. Am J Neuroradiol 31:60–66
Hoffman JM, Waskin HA, Schifter T et al (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34:567–575
Villringer K, Jager H, Dichgans M et al (1995) Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532–536
Mohile NA, DeAngelis LM, Abrey LE (2008) Utility of brain FDG-PET in primary CNS lymphoma. Clin Adv Hematol Oncol 6:818–820
Fischer L, Martus P, Weller M et al (2008) Meningeal dissemination in primary CNS lymphoma. Neurology 71:1102–1108
Galoin S, Daste G, Apoil P-A et al (1997) Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement by B-cell lymphoma and leukaemia: a novel strategy and its implications. Br J Haematol 99:122–130
Rhodes CM, Glantz MJ, Glantz L et al (1996) A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 77:543–548
Storch-Hagenlocher B, Haas J, Vogt-Schaden ME et al (2000) Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis. Ann Neurol 47(2):211–217
Chan CC, Wallace DJ (2004) Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285–295
Grimm SA, McCannel CA, Omuro AMP et al (2008) Primary CNS lymphoma with intraocular involvement. International PCNSL collaborative group report. Neurology 71:1355–1360
Sherman ME, Erozan YS, Mann RB et al (1991) Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am J Clin Pathol 95(6):878–883
Apuzzo ML, Sabshin JK (1983) Computed tomographic guidance stereotaxis in the management of intracranial mass lesions. Neurosurgery 12(3):277–285
Bellinzona M, Roser F, Ostertag H et al (2005) Surgical removal of primary central nervous system lymphomas presenting as space occupying lesions. Eur J Surg Oncol 31:100–105
Abrey LE, Batchelor TT, Ferreri AJ et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034–5043
Ferreri AJM, Reni M, Pasini F et al (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58:1513–1520
DeAngelis LM (1999) Primary central nervous system lymphoma. Curr Opin Neurol 12(6):687–691
Nasir S, DeAngelis LM (2000) Update on the management of primary CNS lymphoma. Oncology 14(2):228–244
O’Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM (1995) Occult systemic non-Hodgkin’s lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): How much staging is enough?. J Neurooncol 25(1):67–71
Mohile NA, Deangelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neurooncology 10:223–228
Jahnke K, Hummel M, Korfel A et al (2006) Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. J Clin Oncol 24:4754–4757
McCann KJ, Ashton-Key M, Smith K et al (2009) Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence of separate development. Blood 113:4677–4680
Buggage RR, Chan C-C, Nussenblat RB (2001) Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 13(3):137–142
Ferreri AJ, Blay JY, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: the international extranodal lymphoma study group experience. J Clin Oncol 21:266–272
Abrey LE, Ben-Porat L, Panageas KS et al (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24:5711–5715
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Batchelor, T., Neuwelt, E., Wang, D.L., Gonzalez, R.G. (2012). Clinical and Diagnostic Considerations in Primary Central Nervous System Lymphoma. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7668-0_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7667-3
Online ISBN: 978-1-4419-7668-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)